C12: A New Anti-Inflammatory Compound
Author Information
Author(s): Wang Yi, Yu Congcong, Pan Yong, Li Jianling, Zhang Yali, Ye Faqing, Yang Shulin, Zhang Hui, Li Xiaokun, Liang Guang
Primary Institution: Wenzhou Medical College
Hypothesis
Can the novel compound C12 effectively inhibit inflammatory processes in vitro and in vivo?
Conclusion
C12 has multiple anti-inflammatory effects and may be useful in treating inflammatory diseases due to its low toxicity and hydrosolubility.
Supporting Evidence
- C12 inhibited the production of proinflammatory cytokines in mouse macrophages.
- C12 reduced mortality in endotoxemic mice.
- C12 showed significant inhibition of inflammatory gene expression in mouse liver.
- C12 improved lung histopathology in mice after LPS administration.
- C12 treatment prolonged survival in an acute inflammatory model.
Takeaway
C12 is a new medicine that helps reduce inflammation and pain in the body, making it a good option for treating diseases that cause swelling.
Methodology
The study involved in vitro tests on mouse macrophages and in vivo tests on mice to evaluate the effects of C12 on inflammatory responses.
Participant Demographics
Male ICR and C57BL/6 mice were used in the experiments.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website